Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder

Autor: Stephanie M. Y. Wong, Y. N. Suen, Charlotte W. C. Wong, Sherry K. W. Chan, Christy L. M. Hui, W. C. Chang, Edwin H. M. Lee, Calvin P. W. Cheng, Garrett C. L. Ho, Gladys Goh Lo, Eric Y. L. Leung, Paul K. M. Au Yeung, Sirong Chen, William G. Honer, Henry K. F. Mak, P. C. Sham, Peter J. McKenna, Edith Pomarol-Clotet, Mattia Veronese, Oliver D. Howes, Eric Y. H. Chen
Rok vydání: 2022
Předmět:
Zdroj: Psychopharmacology. 239:2133-2141
ISSN: 1432-2072
0033-3158
DOI: 10.1007/s00213-022-06088-7
Popis: How striatal dopamine synthesis capacity (DSC) contributes to the pathogenesis of negative symptoms in first-episode schizophrenia (SZ) and delusional disorder (DD) has seldom been explored. As negative symptoms during active psychotic episodes can be complicated by secondary influences, such as positive symptoms, longitudinal investigations may help to clarify the relationship between striatal DSC and negative symptoms and differentiate between primary and secondary negative symptoms.A longitudinal study was conducted to examine whether baseline striatal DSC would be related to negative symptoms at 3 months in first-episode SZ and DD patients.Twenty-three first-episode age- and gender-matched patients (11 DD and 12 SZ) were consecutively recruited through an early intervention service for psychosis in Hong Kong. Among them, 19 (82.6%) patients (9 DD and 10 SZ) were followed up at 3 months. All patients received anBaseline striatal DSC (KThese findings highlight the role of striatal DSC in negative symptoms upon resolution of active psychotic episodes among first-episode SZ patients. Baseline striatal dopamine activity may inform future symptom expression with important treatment implications.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje